Autistic Disorder. Childhood autism
Conditions
Interventions
Intervention 1: Tablet L-Carnosine 800 mg/day+ Tablet Risperidon 1-3.5 mg/day as intervention 10 for 10 weeks. Intervention 2: Tablet Risperidone 1-3.5 mg/day +Capsule Placebo as control for 10 weeks.
Treatment - Drugs
Placebo
Tablet L-Carnosine 800 mg/day+ Tablet Risperidon 1-3.5 mg/day as intervention 10 for 10 weeks
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Years to 12 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: 1-DSM-5 clinical diagnosis of autistic disorder, 2-children between the ages of 3 and 12 years ,3- presence of behavioral problems such as aggression, overactivity or repetitive behaviors (indication of treatment with risperidone) Exclusion Criteria:1- Presence of any active medical problem, 2-any diagnosis in Axis I and II except for mental retardation, 3- receiving any psychotropic medications during past two weeks prior to the trial, 5-presence of hepatic disease, 6-history of seizure
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of Autism. Timepoint: Baseline and weeks 5 and 10 after begining of treatment. Method of measurement: Aberrant Behavior Checklist-Community (ABC-C) Rating Scale (Irritability subscale ). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactProf. Shahin Akhondzadeh
Tehran University of Medical Sciences
Outcome results
None listed